Back to News
Market Impact: 0.45

ACN Quantitative Stock Analysis

ACNNDAQ
Company FundamentalsCorporate EarningsCapital Returns (Dividends / Buybacks)Technology & InnovationAnalyst Insights
ACN Quantitative Stock Analysis

Accenture PLC (ACN) has received an 85% rating from Validea's Patient Investor model, which is based on Warren Buffett's investment strategy, indicating significant interest. This assessment highlights ACN's strong alignment with criteria for predictable profitability, low debt, and reasonable valuations. The analysis confirmed robust fundamentals, with the company passing tests for earnings predictability, debt service, return on equity, return on total capital, free cash flow, and expected return, positioning it as a strong candidate for long-term value-oriented portfolios.

Analysis

Accenture PLC (ACN) has received a significantly positive fundamental assessment from Validea, scoring 85% on its Patient Investor model, which is based on the investment principles of Warren Buffett. This score indicates a strong alignment with criteria for long-term, predictable profitability, low debt, and reasonable valuation. The analysis highlights ACN's robust financial health, as the company passed critical tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow generation. This suggests a history of consistent performance and efficient capital management. The only metric that did not receive a 'PASS' was share repurchase, which was rated 'Neutral'. As a large-cap growth stock within the Computer Services industry, this report positions ACN as a company that also exhibits strong defensive and value-oriented characteristics, making it a noteworthy candidate for quality-focused portfolios.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo